{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:29:41Z","timestamp":1790288981770,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["25ZR1401367"],"award-info":[{"award-number":["25ZR1401367"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-025-04353-6","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T02:05:43Z","timestamp":1764641143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytopathologic features of mesonephric-like adenocarcinoma in the endometrium and ovary: eight cases and literature review"],"prefix":"10.1007","author":[{"given":"Lei","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2402-4774","authenticated-orcid":false,"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"4","key":"4353_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.21873\/cgp.20338","volume":"19","author":"HG Kim","year":"2022","unstructured":"Kim HG, Kim H, Yeo MK, Won KY, Kim YS, Han GH, Kim HS, Na K (2022) Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive analyses of clinicopathological, molecular, and prognostic characteristics with retrospective review of 237 endometrial carcinoma cases. Cancer Genomics Proteomics 19(4):526\u2013539","journal-title":"Cancer Genomics Proteomics"},{"issue":"7","key":"4353_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/PAS.0000000000001873","volume":"46","author":"AM Mills","year":"2022","unstructured":"Mills AM, Jenkins TM, Howitt BE, Fan J, Ring KL, Cook I (2022) Mesonephric-like endometrial carcinoma: results from immunohistochemical screening of 300 endometrial carcinomas and carcinosarcomas for this often overlooked and potentially aggressive entity. Am J Surg Pathol 46(7):921\u2013932","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"4353_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/his.12895","volume":"68","author":"M McFarland","year":"2016","unstructured":"McFarland M, Quick CM, McCluggage WG (2016) Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. Histopathology 68(7):1013\u20131020","journal-title":"Histopathology"},{"issue":"4","key":"4353_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/PAS.0000000000001401","volume":"44","author":"ED Euscher","year":"2020","unstructured":"Euscher ED, Bassett R, Duose DY, Lan C, Wistuba I, Ramondetta L, Ramalingam P, Malpica A (2020) Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior. Am J Surg Pathol 44(4):429\u2013443","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4353_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","volume":"45","author":"J Pors","year":"2021","unstructured":"Pors J, Segura S, Chiu DS, Almadani N, Ren H, Fix DJ, Howitt BE, Kolin D, McCluggage WG, Mirkovic J, Gilks B, Park KJ, Hoang L (2021) Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: a multi-institutional study. Am J Surg Pathol 45(4):498\u2013506. https:\/\/doi.org\/10.1097\/PAS.0000000000001612","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"4353_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/PAS.0000000000002039","volume":"47","author":"ED Euscher","year":"2023","unstructured":"Euscher ED, Marques-Piubelli ML, Ramalingam P, Wistuba I, Lawson BC, Frumovitz M, Malpica A (2023) Extrauterine mesonephric-like carcinoma: a comprehensive single institution study of 33 cases. Am J Surg Pathol 47(6):635\u2013648","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4353_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/his.14609","volume":"80","author":"WG McCluggage","year":"2022","unstructured":"McCluggage WG, Singh N, Gilks CB (2022) Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology 80(5):762\u2013778","journal-title":"Histopathology"},{"key":"4353_CR8","doi-asserted-by":"crossref","unstructured":"Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N; Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee (2023) FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet 162(2):383-394","DOI":"10.1002\/ijgo.14923"},{"issue":"12","key":"4353_CR9","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1097\/00000478-200112000-00011","volume":"25","author":"J Ordi","year":"2001","unstructured":"Ordi J, Nogales FF, Palacin A, Marquez M, Pahisa J, Vanrell JA, Cardesa A (2001) Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation. Am J Surg Pathol 25(12):1540\u20131545","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"4353_CR10","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","volume":"42","author":"J Pors","year":"2018","unstructured":"Pors J, Cheng A, Leo JM, Kinloch MA, Gilks B, Hoang L (2018) A comparison of GATA3, TTF1, CD10, and calretinin in identifying mesonephric and mesonephric-like carcinomas of the gynecologic tract. Am J Surg Pathol 42(12):1596\u20131606","journal-title":"Am J Surg Pathol"},{"key":"4353_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11112042","author":"H Kim","year":"2021","unstructured":"Kim H, Na K, Bae GE, Kim HS (2021) Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive immunohistochemical analyses using markers for mesonephric, endometrioid and serous tumors. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics11112042","journal-title":"Diagnostics"},{"key":"4353_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040698","author":"E Deolet","year":"2021","unstructured":"Deolet E, Van Dorpe J, de Van Vijver K (2021) Mesonephric-like adenocarcinoma of the endometrium: diagnostic advances to spot this wolf in sheep\u2019s clothing. A review of the literature. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10040698","journal-title":"J Clin Med"},{"issue":"7","key":"4353_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/his.14892","volume":"82","author":"J Mirkovic","year":"2023","unstructured":"Mirkovic J, Olkhov-Mitsel E, Amemiya Y, Al-Hussaini M, Nofech-Mozes S, Djordjevic B, Kupets R, Seth A, McCluggage WG (2023) Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas. Histopathology 82(7):978\u2013990","journal-title":"Histopathology"},{"issue":"4","key":"4353_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","volume":"146","author":"LC Horn","year":"2020","unstructured":"Horn LC, Hohn AK, Krucken I, Stiller M, Obeck U, Brambs CE (2020) Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma. J Cancer Res Clin Oncol 146(4):971\u2013983","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"4353_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","volume":"43","author":"DL Kolin","year":"2019","unstructured":"Kolin DL, Costigan DC, Dong F, Nucci MR, Howitt BE (2019) A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium. Am J Surg Pathol 43(3):389\u2013398","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"4353_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cncy.22160","volume":"127","author":"B Kezlarian","year":"2019","unstructured":"Kezlarian B, Muller S, Werneck Krauss Silva V, Gonzalez C, Fix DJ, Park KJ, Murali R (2019) Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric-like differentiation. Cancer Cytopathol 127(8):521\u2013528. https:\/\/doi.org\/10.1002\/cncy.22160","journal-title":"Cancer Cytopathol"},{"issue":"6","key":"4353_CR17","doi-asserted-by":"publisher","first-page":"E207","DOI":"10.1002\/dc.24675","volume":"49","author":"M Qazi","year":"2021","unstructured":"Qazi M, Movahedi-Lankarani S, Wang BG (2021) Cytohistopathologic correlation of ovarian mesonephric-like carcinoma and female adnexal tumor of probable Wolffian origin. Diagn Cytopathol 49(6):E207\u2013E213","journal-title":"Diagn Cytopathol"},{"issue":"11","key":"4353_CR18","doi-asserted-by":"publisher","first-page":"E325","DOI":"10.1002\/dc.25009","volume":"50","author":"S Besharati","year":"2022","unstructured":"Besharati S, Liu-Jarin X, Chen X, Cimic A (2022) An unusual case of carcinoma with mesonephric-like features with a spindle cell component diagnosed on the Pap test of the uterine cervix: cytomorphologic and immunophenotypic features and diagnostic pitfalls. Diagn Cytopathol 50(11):E325\u2013E329. https:\/\/doi.org\/10.1002\/dc.25009","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"4353_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/dc.24917","volume":"50","author":"NL Hardy","year":"2022","unstructured":"Hardy NL, Staats PN (2022) Metastatic mesonephric-like endometrial adenocarcinoma diagnosed on transbronchial needle aspirate cytology. Diagn Cytopathol 50(2):86\u201390","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"4353_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/dc.25111","volume":"51","author":"Y Seo","year":"2023","unstructured":"Seo Y, Park E, Kim HS (2023) Cytological features of mesonephric-like adenocarcinoma of the uterine corpus. Diagn Cytopathol 51(5):294\u2013306","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"4353_CR21","doi-asserted-by":"publisher","first-page":"E129","DOI":"10.1002\/dc.25300","volume":"52","author":"H Omine","year":"2024","unstructured":"Omine H, Ishida K, Sasaki N, Kato H, Nagai T, Ishikawa M, Takaoka M, Noda S, Matsuda H, Mitsuhashi A (2024) Endometrial cytological findings for a mesonephric-like endometrial adenocarcinoma: a case report. Diagn Cytopathol 52(6):E129\u2013E133. https:\/\/doi.org\/10.1002\/dc.25300","journal-title":"Diagn Cytopathol"},{"key":"4353_CR22","doi-asserted-by":"crossref","unstructured":"Nayar R, Wilbur DC. 3rd ed. Switzerland: Springer International Publishing; (2015) The Bethesda System for Reporting Cervical Cytology-definitions, Criteria and Explanatory Notes","DOI":"10.1007\/978-3-319-11074-5"},{"key":"4353_CR23","doi-asserted-by":"crossref","unstructured":"Singh N, Piskorz AM, Bosse T, Jimenez\u2010Linan M, Rous B, Brenton JD, Gilks CB, Martin K (2020) p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies. J Pathol 250(3):336-345","DOI":"10.1002\/path.5375"},{"issue":"1","key":"4353_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/path.6217","volume":"262","author":"FK Kommoss","year":"2024","unstructured":"Kommoss FK, Lee CH, Tessier-Cloutier B, Gilks CB, Stewart CJ, von Deimling A, Kobel M (2024) Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix. J Pathol 262(1):4\u20139","journal-title":"J Pathol"},{"issue":"2","key":"4353_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/path.6285","volume":"263","author":"LH Lin","year":"2024","unstructured":"Lin LH, Howitt BE, Kolin DL (2024) From morphology to methylome: epigenetic studies of Mullerian mesonephric-like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma(dagger). J Pathol 263(2):135\u2013138","journal-title":"J Pathol"},{"issue":"1","key":"4353_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","volume":"43","author":"K Na","year":"2019","unstructured":"Na K, Kim HS (2019) Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body. Am J Surg Pathol 43(1):12\u201325. https:\/\/doi.org\/10.1097\/PAS.0000000000000991","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"4353_CR27","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","volume":"34","author":"EM da Silva","year":"2021","unstructured":"da Silva EM, Fix DJ, Sebastiao APM, Selenica P, Ferrando L, Kim SH, Stylianou A, Da Cruz PA, Pareja F, Smith ES et al (2021) Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases. Mod Pathol 34(8):1570\u20131587","journal-title":"Mod Pathol"},{"issue":"2","key":"4353_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","volume":"42","author":"J Mirkovic","year":"2018","unstructured":"Mirkovic J, McFarland M, Garcia E, Sholl LM, Lindeman N, MacConaill L, Dong F, Hirsch M, Nucci MR, Quick CM, Crum CP, McCluggage WG, Howitt BE (2018) Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract. Am J Surg Pathol 42(2):227\u2013233. https:\/\/doi.org\/10.1097\/PAS.0000000000000958","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4353_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/PGP.0000000000000444","volume":"37","author":"DB Chapel","year":"2018","unstructured":"Chapel DB, Joseph NM, Krausz T, Lastra RR (2018) An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a mullerian origin for some mesonephric carcinomas. Int J Gynecol Pathol 37(5):448\u2013459","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"4353_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0768-9","volume":"7","author":"AA Davis","year":"2019","unstructured":"Davis AA, Patel VG (2019) The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors. J Immunother Cancer 7(1):278. https:\/\/doi.org\/10.1186\/s40425-019-0768-9","journal-title":"J Immunother Cancer"},{"issue":"5","key":"4353_CR31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/PAS.0000000000002030","volume":"47","author":"AS Joehlin-Price","year":"2023","unstructured":"Joehlin-Price AS, Komforti MK, Ladwig NR, Devine P, Hoyle C, McCoy L, Sprague C, Astbury C, Hoda R, Chen YY et al (2023) HER2 IHC expression and gene amplification in p53-aberrant high-grade endometrial endometrioid carcinoma suggests that this population may benefit from HER2 testing and targeted therapy. Am J Surg Pathol 47(5):580\u2013588","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4353_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/PGP.0b013e3182774562","volume":"32","author":"DJ O'Shannessy","year":"2013","unstructured":"O\u2019Shannessy DJ, Somers EB, Smale R, Fu YS (2013) Expression of folate receptor-alpha (FRA) in gynecologic malignancies and its relationship to the tumor type. Int J Gynecol Pathol 32(3):258\u2013268","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"4353_CR33","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.21873\/invivo.12667","volume":"35","author":"H Kim","year":"2021","unstructured":"Kim H, Bae GE, Jung YY, Kim HS (2021) Ovarian mesonephric-like adenocarcinoma with multifocal microscopic involvement of the fimbrial surface: potential for misdiagnosis of tubal intraepithelial metastasis as serous tubal intraepithelial carcinoma associated with ovarian high-grade serous carcinoma. In Vivo 35(6):3613\u20133622","journal-title":"In Vivo"},{"issue":"1","key":"4353_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2203690","volume":"387","author":"S Modi","year":"2022","unstructured":"Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga J-Y, Im S-A, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim S-B, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA (2022) Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer. N Engl J Med 387(1):9\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2203690","journal-title":"N Engl J Med"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04353-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T02:05:46Z","timestamp":1764641146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04353-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":34,"alternative-id":["4353"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04353-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}